ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Bone marrow transplantation"

  • 2021 American Transplant Congress

    Bone Marrow-Derived Mesenchymal Stem Cells Improve Rat Islet Graft Revascularization by Upregulating Isl1

    W. Ying, J. Wang, X. Ding

    Kidney Transplantation, The First Affiliated Hospital of Xi'an Jiaotong University, Xi An, China

    *Purpose: Revascularization of the transplant islet is a crucial step that defines the success rate of patient recovery. Though bone marrow-derived mesenchymal stem cells (BMSCs)…
  • 2021 American Transplant Congress

    Kidney Injury in Hematopoietic Cell Transplant (HCT) Recipients: Urinary Biomarkers to the Rescue

    T. Salinas1, C. Snopkowski1, C. Li1, K. Chen1, M. Lubetzky1, S. Salvatore1, K. Van Besien1, E. Jaimes2, S. Hingorani3, S. Seshan1, T. Muthukumar1

    1NY Presbyterian- Weill Cornell Medical College, New York, NY, 2Memorial Sloan Kettering Cancer Center, New York, NY, 3University of Washington School of Medicine, Seattle, WA

    *Purpose: Kidney injury is common in HCT recipients and can be the result of graft versus host/kidney disease. However, this has not been well characterized,…
  • 2021 American Transplant Congress

    BKV-Associated Urothelial Carcinoma in Patients After Renal and Extrarenal Carcinoma

    A. Schwarz1, J. Schmitz2, J. Gottlieb3, C. Bara4, H. Haller1, J. Braesen2

    1Nephrology Department, Hannover Medical School, Hannover, Germany, 2Institute of Pathology, Hannover Medical School, Hannover, Germany, 3Department of Pneumology, Hannover Medical School, Hannover, Germany, 4Department of Thoracic Surgery, Hannover Medical School, Hannover, Germany

    *Purpose: Polyomavirus BK (BKV) reactivation or transmission is a wellknown problem in renal transplant (TX) patients with BKV nephropathy and interstitial cystitis. The role of…
  • 2021 American Transplant Congress

    Polyomavirus BK-Associated Nephropathy in Patients After Renal and Extrarenal Transplantation

    A. Schwarz1, J. Schmitz2, J. Braesen2, C. Bara3, M. Sauer4, H. Haller1, J. Gottlieb5

    1Nephrology Department, Hannover Medical School, Hannover, Germany, 2Institute of Pathology, Hannover Medical School, Hannover, Germany, 3Department of Thoracic Surgery, Hannover Medical School, Hannover, Germany, 4Department of Pediatric Hematology, Hannover Medical School, Hannover, Germany, 5Deparment of Pneumology, Hannover Medical School, Hannover, Germany

    *Purpose: Patients with non-renal organ transplantation (TX) may suffer BK-viral nephropathy (BKVN) of their own orthotopic kidneys. We aimed to know if these patients with…
  • 2020 American Transplant Congress

    Incidence of Non-Tuberculous Mycobacteria in the Transplant Population at a University Transplant Center in Northern Florida

    D. Schain, Z. Breslow, G. El Helou, A. Cannella

    Medicine/IDGM, Univ of Florida, College of Med, Gainesville, FL

    *Purpose: Over the past decade, there has been an increase in the number of non-tuberculous mycobacteria (NTM) infections in the United States, especially in the…
  • 2020 American Transplant Congress

    Successful Use of Tedizolid for the Treatment of Nocardiosis in Transplant Recipients

    R. Odrobina1, B. Tritle2, C. A.Gomez1

    1Division of Infectious Diseases, University of Utah, Salt Lake City, UT, 2Department of Pharmacy, University of Utah, Salt Lake City, UT

    *Purpose: Nocardiosis is an opportunistic infection occasionally seen after solid organ (SOT) and hematopoietic stem-cell transplantation. Treatment is challenging due to the limited number of…
  • 2020 American Transplant Congress

    Hematopoietic Cell Transplantation and Solid Organ Transplantation: Outcomes of Sequential Transplantation in the United States

    M. Gupta1, M. Levine2, D. Porter2, R. Brazauskas3, S. Bo-Subait4, R. Phelan3, M. Battiwalla5, D. Buchbinder6, B. Hamilton7, B. Shaw3, P. Abt2

    1University of Kentucky, Lexington, KY, 2University of Pennsylvania, Philadelphia, PA, 3Medical College of Wisconsin, Milwaukee, WI, 4CIBMTR, NMDP, Minneapolis, MN, 5Sarah Cannon Blood Cancer Network, Nashville, TN, 6Children's Hospital of Orange County, Orange, CA, 7Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH

    *Purpose: Survival after solid organ transplantation(SOT) and hematopoietic cell transplantation(HCT) has steadily risen. Despite these improvements, SOT recipients may develop conditions requiring HCT, and HCT…
  • 2020 American Transplant Congress

    Induction of Delayed Immune Tolerance after Reconstructive Transplantation by Combining Donor Bone Marrow Transplantation and High-Dose Cyclophosphamide Treatment

    Y. Guo1, F. Messner1, B. Oh1, G. Furtmüller1, W. Lee1, D. Cooney1, L. Luznik2, G. Brandacher1

    1Plastic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 2Hematology, Johns Hopkins University School of Medicine, Baltimore, MD

    *Purpose: Immunosuppression avoidance by induction of immune tolerance represents a primary goal in the field of transplantation. Yet, success of this concept relies on extensive…
  • 2020 American Transplant Congress

    Long-Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients

    J. Leventhal1, J. Mathew1, J. Galvin2, L. Gallon1, D. Belshe1, K. Ravindra3, M. Horwitz3, J. Miller1, S. Ildstad4

    1Northwestern, Chicago, IL, 2UIC, Chicago, IL, 3Duke, Durham, NC, 4U Louisville, Louisville, KY

    *Purpose: 37 pts have been transplanted since 2009 in a phase 2 protocol to induce tolerance in recipients of living donor renal allografts (KTx). The…
  • 2020 American Transplant Congress

    Orthogonal IL-2 Cytokine-Receptor Pair Capable of Selective Expansion of Regulatory T Cells Facilitates Alloengraftment

    T. Hirai1, F. Simonetta2, L. L. Su3, L. Picton3, J. Baker2, J. Lin4, P. Li4, W. J. Leonard4, K. C. Garcia3, R. S. Negrin2

    1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan, 2Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, 3Departments of Molecular and Cellular Physiology and Structural Biology, Stanford University, Stanford, CA, 4Laboratory of Molecular Immunology, National Institutes of Health, Bethesda, MD

    *Purpose: Adoptive transfer of regulatory T cells (Tregs) has been shown to improve alloengraftment in animal models. However, ex vivo Treg expansion for the purpose…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 9
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences